Less Ads, More Data, More Tools Register for FREE

Pin to quick picksM P Evans Regulatory News (MPE)

Share Price Information for M P Evans (MPE)

Share Price is delayed by 15 minutes
Get Live Data
1,502.00    -48.00 (-3.10%)
Bid:
1,494.00
Ask:
1,498.00
Spread: 4.00 (0.268%)
Market Cap: £783.50m
MPE Live PriceLast checked at - London Stock Exchange

Intraday M P Evans Share Chart

Crop and production

16 Jan 2023 07:00

RNS Number : 7036M
M. P. Evans Group PLC
16 January 2023
 

M. P. EVANS GROUP PLC

("THE GROUP")2022 crop and production

M.P. Evans Group PLC, the producer of sustainable Indonesian palm oil, is pleased to announce the following crop and production information for the year ended 31 December 2022:

2022

Increase

2021

Tonnes

%

Tonnes

Crop of fresh fruit bunches ("ffb")

Own crops

905,400

12

809,700

Scheme-smallholder crops

265,700

16

229,300

Independent crops purchased

340,600

4

327,200

1,511,700

11

1,366,200

Production*

Crude palm oil ("CPO")

341,700

9

312,900

Palm kernels ("PK")

73,800

10

67,100

*- figures include production from the Group's crop sold to third-party mills.

Crop and production increased once again in 2022, as the Group's oil-palm estates continue to mature and yields rise, and management in Indonesia strive for operational excellence in both estate and milling operations. Even after another year of increase, further production growth from the Group's existing areas is still to come.

During 2022, the Group achieved an average mill-gate price for its CPO of US$854 per tonne compared with US$810 in the previous year, an increase of 5%. Prices for palm kernels averaged US$611 per tonne (mill gate), 15% higher than the US$533 in 2021. CPO pricing moderated somewhat in the second half of 2022 from the very high levels seen in the first half of the year, and moving into early 2023, the Group has recently achieved mill-gate prices of approximately US$750 per tonne, which remain strong compared to historic levels.

The Group remains committed to the production of certified sustainable palm oil and is close to completing its sixth palm-oil mill at its Musi Rawas project in South Sumatra. This mill will process the increasing amount of crop being harvested from that estate. The Group is also pleased to report that it received total sustainability premia of US$7.5 million related to the sale of its certified sustainable output, 74% higher than the US$4.3 million received in 2021, reflecting in particular a strong increase in premia available for sustainably produced palm kernels.

Over the course of 2022, the Group continued to be strongly cash generative. The remaining net debt at the start of the year of US$5.4 million was eliminated, and even after ongoing capital investment, an increased dividend and restarting the share buyback programme, net cash was over US$30 million by the end of the year. This supports the Group's stated strategy of acquiring additional plantation land. A number of potential acquisitions remain under review.

Considering the reported crop growth, the strong CPO price environment observed in the year, and the ongoing cash generation, the board remains committed to its policy to hold or increase its dividend, under which it has an unbroken track record of more than thirty years.

M.P. Evans executive chairman, Peter Hadsley-Chaplin, commented: "The Group has achieved another significant increase in crop processed which, in conjunction with the high price environment in the year, will form the basis for an excellent result. We anticipate further crop increases from the Group's first-class estates and, with the Musi Rawas mill soon to be commissioned, we look forward to another productive and successful year in 2023."

Enquiries:

M.P. Evans Group PLC

Telephone: +44 (0) 1892 516333

Peter Hadsley-Chaplin, Chairman Matthew Coulson, Chief executiveLuke Shaw, Chief financial officer

Peel Hunt LLP (Nomad and joint broker)

Telephone: +44 (0) 20 7418 8900

Dan Webster, Andrew Clark, Lalit Bose

finnCap (Joint broker)

Telephone: +44 (0) 20 7220 0500

Tim Redfern, Harriet Ward

Hudson Sandler (Financial PR)

Telephone: +44 (0) 20 7796 4133

Charlie Jack, Francis Kerrigan, Amelia Craddock

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCZZGMMMFMGFZM
Date   Source Headline
4th Jun 20267:00 amRNSTransaction in Own Shares
3rd Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20267:00 amRNSTransaction in Own Shares
1st Jun 20267:30 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
29th May 20267:00 amRNSTransaction in Own Shares
28th May 20267:00 amRNSTransaction in Own Shares
26th May 20262:42 pmRNSShare Buyback Programme
20th May 202611:26 amRNSIndonesian commodity exporting
12th May 20262:52 pmRNSAGM Arrangements
1st Apr 20265:40 pmRNS2025 Annual Report
26th Mar 202610:16 amRNSDirector/PDMR Shareholding
24th Mar 20267:00 amRNSFinal Results 2025
5th Mar 20267:00 amRNSNotice of Results
23rd Jan 20267:00 amRNSDirector/PDMR Shareholding
22nd Jan 20267:00 amRNS2025 Crop and production
16th Jan 20261:05 pmRNSDirector/PDMR Shareholding
6th Jan 20267:00 amRNSDirector/PDMR Shareholding
18th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 202512:58 pmRNSPublication of 2024 ESG report
2nd Dec 20251:14 pmRNSCompany update
1st Dec 20257:00 amRNSAppointment of joint broker
10th Nov 20257:00 amRNSStrong pricing during second half of 2025
28th Oct 20255:33 pmRNSHolding(s) in Company
22nd Sep 20253:26 pmRNSAIM Rule 20
15th Sep 20257:00 amRNSHalf-year Report
27th Aug 20257:00 amRNSNotice of interim results & investor presentation
29th Jul 20257:00 amRNSPublication of TCFD report
24th Jul 20257:00 amRNS2025 H1 crop and production
14th Jul 202510:07 amRNSAcquisition
7th Jul 20254:54 pmRNSDirector/PDMR Shareholding
30th Jun 20254:30 pmRNSTotal Voting Rights
25th Jun 202511:18 amRNSIssue of Equity
18th Jun 20257:00 amRNSShare buyback programme
13th Jun 20251:45 pmRNSResult of AGM
13th Jun 20257:00 amRNSAGM Statement
12th Jun 20254:50 pmRNSAppointment to board roles
5th Jun 20257:00 amRNSAGM update
14th May 20257:00 amRNSDirectorate Change
22nd Apr 20255:33 pmRNSDirector/PDMR Shareholding
16th Apr 202511:00 amRNSAcquisition
31st Mar 20254:02 pmRNSPosting of Annual Report
25th Mar 20257:00 amRNSFinal Results
21st Mar 20257:00 amRNSDirector retirement
5th Mar 20257:00 amRNSNotice of Results and investor presentation
20th Jan 20253:05 pmRNSDirector/PDMR Shareholding
20th Jan 20257:00 amRNSCrop and production
2nd Jan 202511:31 amRNSDirector/PDMR Shareholding
2nd Jan 20257:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.